Elsevier

The Lancet Psychiatry

Volume 3, Issue 9, September 2016, Pages 850-859
The Lancet Psychiatry

Articles
Removing transgender identity from the classification of mental disorders: a Mexican field study for ICD-11

https://doi.org/10.1016/S2215-0366(16)30165-1Get rights and content

Summary

Background

The conceptualisation of transgender identity as a mental disorder has contributed to precarious legal status, human rights violations, and barriers to appropriate health care among transgender people. The proposed reconceptualisation of categories related to transgender identity in WHO's forthcoming International Classification of Diseases (ICD)-11 removes categories related to transgender identity from the classification of mental disorders, in part based on the idea that these conditions do not satisfy the definitional requirements of mental disorders. We aimed to determine whether distress and impairment, considered essential characteristics of mental disorders, could be explained by experiences of social rejection and violence rather than being inherent features of transgender identity, and to examine the applicability of other elements of the proposed ICD-11 diagnostic guidelines.

Methods

This field study used a retrospective interview design in a purposive sample of transgender adults (aged >18 years or older) receiving health-care services at the Condesa Specialised Clinic in Mexico City, Mexico. Participants completed a detailed structured interview focusing on sociodemographic characteristics, medical history related to gender identity, and, during a specific period of adolescence, key concepts related to gender identity diagnoses as proposed for ICD-11 and from DSM-5 and ICD-10, psychological distress, functional impairment, social rejection, and violence. Data were analysed with descriptive statistics and univariate comparisons and multivariate logistic regression models predicting distress and dysfunction.

Findings

Between April 1, 2014, and Aug 17, 2014, 260 transgender adults were approached and 250 were enrolled in the study and completed the interview. Most (n=202 [81%]) had been assigned a male sex at birth. Participants reported first awareness of transgender identity at a mean age of 5·6 years (SD 2·5, range 2–17), and 184 (74%) had used health interventions for body transformation, most commonly hormones (182 [73%)], with the first such intervention at a mean age of 25·0 years (SD 9·1, range 10–54). 84 (46%) of those who had used hormones did so initially without medical supervision. During adolescence, distress related to gender identity was very common, but not universal (n=208 [83%]), and average level of distress was quite high among those who reported it (79·9 on a scale of 0 [none at all] to 100 [extreme], SD 20·7, range 20–100). Most participants (n=226 [90%] reported experiencing family, social, or work or scholastic dysfunction related to their gender identity, but this was typically moderate (on a scale of 0 [not at all disrupted] to 10 [extremely disrupted], family dysfunction mean 5·3 [SD 3·9, range 0–10]; social dysfunction mean 5·0 [SD 3·8, range 0–10]; work or scholastic dysfunction mean 4·8 [SD 3·6, range 0–10]). Multivariate logistic regression models indicated that distress and all types of dysfunction were strongly predicted by experiences of social rejection (odds ratios [ORs] 2·29–8·15) and violence (1·99–3·99). A current male gender identity also predicted distress (OR 3·90). Of the indicators of gender incongruence, only asking to be treated as a different gender was a significant predictor, and only of work or scholastic dysfunction (OR 1·82).

Interpretation

This study provides additional support for classifying health-related categories related to transgender identity outside the classification of mental disorders in the ICD-11. The reconceptualisation and related reclassification of transgender-related health conditions in the ICD-11 could serve as a useful instrument in the discussion of public health policies aimed at increasing access to appropriate services and reducing the victimisation of transgender people.

Funding

National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico.

Introduction

The WHO is currently revising the International Classification of Diseases (ICD)-10,1 and ICD-11 is expected to be approved in May, 2018. WHO's 194 Member States use the ICD as the international standard for the collection and reporting of health information, and in many countries it is used as a part of the framework for defining governments' obligations to provide free or subsidised health services to their populations; other public and private insurers also use ICD health conditions as a basis for defining eligibility and covered services.2

The classification of conditions related to transgender identity has been controversial.3, 4, 5 This controversy must be understood in the context of serious health disparities, poor access to health services, and experiences of systematic discrimination and violence among transgender people around the world.6, 7 WHO's recent report on “Sexual health, human rights, and the law”8 described how poor access to accurate information and appropriate health services can have serious behavioural and mental health consequences for transgender people, including increased HIV-related risk behaviour, anxiety, depression, substance abuse, and suicide.9, 10 Public and private insurers in many countries often do not provide coverage for transgender-related health services.7, 8, 11

Research in context

Evidence before this study

Current classification systems of mental disorders, including WHO's International Classification of Diseases (ICD)-10 and the American Psychiatric Association's DSM-5, include categories related to transgender identity. These classifications are important in part because in many countries they determine access to health services, but the view of transgender people as having a mental disorder has been increasingly controversial, with calls from many parties, including the European Parliament, to facilitate access to health services for this population in some other way. A WHO Working Group on Sexual Disorders and Sexual Health, comprising experts from all WHO regions, recommended renaming these categories as gender incongruence and moving them to a new proposed ICD-11 chapter on Conditions Related to Sexual Health, which is conceptualised as a more medical chapter. DSM-5 has managed these categories differently, renaming them as gender dysphoria and continuing to classify them as mental disorders, partly based on the rationale that distress or dysfunction are essential elements of the condition. Whether distress and dysfunction in this population should be more appropriately viewed as the result of social rejection, stigmatisation, and violence toward individuals with gender variant appearance and behaviour has provoked substantial questions.

We searched PubMed for all publications in English and Spanish, including meta-analyses and reviews, from January, 1996, to December, 2015, using the terms transgender, trans, transsexual, transsexualism, gender dysphoria, gender incongruence, or gender identity along with the terms violence, stigmatisation, social impairment, or distress. Ample documentation from existing studies shows that transgender people experience high rates of harassment and violence, including sexual violence, not only from strangers but also from their own families and communities. Existing research has provided evidence of associations between experiences of discrimination, social exclusion, and violence and psychological distress, depression, suicide attempts, and elevated risk for HIV infection, with some findings supporting the minority stress model. Other studies have provided evidence of discrimination, stigma, and mistreatment faced by transgender people within the health-care system.

Added value of this study

This results of this first field test of the Working Group's proposals in a relevant health-care setting in a large, middle-income country support the major elements of the ICD-11 proposal. During adolescence, distress was very common among this transgender population, although not universal, and average level of distress was high. Family, social, and work or scholastic dysfunction were also common and typically moderate. However, consistent with previous research on the minority stress model, distress and all types of dysfunction were more strongly predicted by experiences of social rejection and violence than by gender incongruence per se.

Implications of all the available evidence

This study supports the removal of categories related to gender identity from the ICD classification of mental disorders given that distress and dysfunction, considered to be defining features of mental disorders, were not universal and were found to be more strongly related to experiences of stigmatisation and violence than to gender incongruence. Very high observed rates of social rejection and violence experienced by the transgender individuals participating in this study suggest a continuing need for legal protections, social policies, and family interventions to reduce these experiences. This study is being replicated in other countries. The reconceptualisation and related reclassification of transgender-related health conditions in the ICD-11 could serve as a useful instrument in the discussion of public health policies aimed at increasing access to appropriate services and reducing the victimisation of transgender people.

Because of the ICD's important role in defining health conditions and in determining access to health services, retaining health conditions in the ICD-11 related to transgender identity has been widely, although not universally, viewed as necessary in the current global health context.3, 4 In ICD-10, approved in 1990, these categories are called gender identity disorders and are included in the chapter on Mental and Behavioural Disorders.12, 13 However, stigma associated with both transgender status and mental disorders has contributed to precarious legal status, human rights violations, and barriers to appropriate health care among transgender people.6, 7, 8 The definition of conditions related to transgender identity as mental disorders has been used to justify denial of coverage for these conditions by governments and private health plans and has contributed to the perception that transgender people must be treated by psychiatric specialists, further restricting access to services that could be provided at other levels of care. The fact that transgender people have been considered to have a mental disorder has also been misused by some governments to deny self-determination and decision-making authority to transgender people in matters ranging from changing of legal documents to child custody to reproduction.3, 4, 6, 7, 8 In 2011, in a unanimous resolution, the European Parliament called on WHO “to withdraw gender identity disorders from the list of mental and behavioural disorders, and to ensure a non-pathologising reclassification” as a part of the development of ICD-11.14

Categories related to transgender status have been retained in the most recent classification of mental disorders of the American Psychiatric Association, DSM-5.15 DSM-5 renamed gender identity disorder as gender dysphoria, defined by “marked incongruence between one's experienced/expressed gender and assigned gender of at least 6 months' duration” and “clinically significant distress or impairment in social, school, or other important areas of functioning” (p 452). Both the name of the DSM-5 condition—dysphoria—and the diagnostic criteria therefore emphasise distress and dysfunction as integral aspects of the condition and a central rationale for classifying the category as a mental disorder. A challenge to this conceptualisation is the question of whether distress and dysfunction related to the social consequences of gender variance (eg, stigmatisation, violence) can be distinguished from distress related to transgender identity.16, 17

By contrast, the proposal for WHO's ICD-11 is to remove categories related to transgender identity from the Mental and Behavioural Disorders chapter and place them in a new ICD-11 chapter called Conditions Related to Sexual Health,18 which is conceptualised as a more medically oriented chapter. The ICD-11 proposal names the category gender incongruence and emphasises the individual's subjective experience of incongruence between the individual's experienced gender and the assigned sex.3 The proposed diagnostic guidelines note that gender incongruence can be associated with clinically significant distress or impairment in social, occupational, or other important areas of functioning, particularly in disapproving social environments, but neither distress nor functional impairment is a diagnostic requirement.

Mexico, like several other Latin American countries, has some federal protections against discrimination related to gender identity through a general national programme for equality and non-discrimination. Much stronger local protections are in place in Mexico City, where behaviours related to physical or psychological abuse of transgender people and any limitation or restricted access to public spaces, employment, or schools on the basis of gender identity or gender expression are explicitly prohibited. Nevertheless, many transgender people in Mexico City have reported rejection, exclusion, discrimination, and conditions of vulnerability and marginalisation. In one sample of 500 transgender women in Mexico City, 60% had supported themselves through sex work, at least 11% had lived on the street, 25% had been in prison, and a high proportion were HIV positive.19 This study was particularly likely to include marginalised individuals with few economic resources owing to its sampling method, but nonetheless provides an indication of the scope of the challenges faced by this group. Accurate population-based data for the number of transgender people in Mexico City are not available, but a conservative estimate20, 21 would suggest that there are at least 26 700 transgender people among Mexico City's population of 8·9 million and at least 63 600 among the greater metropolitan area's population of about 21·2 million.

Publicly funded health services available to transgender people in Mexico City are scarce. The Condesa Specialised Clinic is the only specialised clinic in the public health-care system in the greater Mexico City area that provides comprehensive services for transgender adults, including hormonal treatment and related medical supervision, psychotherapeutic support, and prevention and treatment of sexually transmitted infections and HIV/AIDS, as appropriate. Individuals are eligible to receive services at Condesa Specialised Clinic only if they have no form of employer-based or private health insurance, so that the clinic mainly serves individuals with few economic resources and many of those who work do so as part of the informal sector. As of the end of 2015, the Condesa Clinic was providing health services to 1395 transgender people. Of these, 1144 (82%) identified as transgender women (trans women) and 16% (n=223) as transgender men (trans men), with the rest identifying in some other way. HIV prevalence among the Condesa population was 40% among trans women and 0% among trans men.22

The aim of this study was to compare the proposed diagnostic elements of ICD-11 gender incongruence, DSM-5 gender dysphoria, and the ICD-10 category transsexualism to transgender people's own self-reported experience of gender incongruence, distress, and dysfunction. Moreover, the study sought to examine whether experiences of distress or dysfunction were universally reported by transgender people in association with their experience of gender incongruence, as would be implied by the conceptualisation of transgender identity as a mental disorder, and whether there was evidence that distress and dysfunction could be attributed to experiences of social exclusion, prejudice, stigmatisation, and violence. This study was done among a sample of transgender people receiving health-care services at the Condesa Specialised Clinic in Mexico City, Mexico, and was the first field test of the ICD-11 proposals for gender incongruence in a relevant health-care setting in a large, middle-income country.

Section snippets

Study design and participants

This was a retrospective interview study of adult transgender people (aged ≥18 years old) who were receiving transgender-related health services at the Condesa Specialised Clinic in Mexico City. The transgender community receiving services at the clinic were informed about the study through an information session organised by clinical leaders and the research team and through flyers and additional information available in the clinic. Transgender individuals receiving services in the Condesa

Results

Between April 1, 2014, and Aug 17, 2014, 260 transgender people indicated that they were willing to consider participating. Of these, five declined to participate after the study was explained by the research assistant, and five did not provide sufficient information during the interview for analysis. Of these ten people, nine were trans women (ie, assigned a male gender at birth). The present analysis is based on the sample of 250 participants who completed the interview.

Most participants had

Discussion

The reports collected by this large retrospective study of transgender people's own experiences support the ICD-11 reconceptualisation of gender incongruence and its removal from the classification of mental disorders in several ways. This is different from the DSM-5 conceptualisation of gender dysphoria, which requires distress or dysfunction for the diagnosis. These aspects of the DSM-5 diagnostic criteria are key because without them gender dysphoria would not fulfil the requirements of

References (38)

  • Sexual health, human rights and the law

    (2015)
  • L Nuttbrock et al.

    Psychiatric impact of gender-related abuse across the life course of male-to-female transgender persons

    J Sex Res

    (2010)
  • E Sugano et al.

    The impact of exposure to transphobia on HIV risk behavior in a sample of transgendered women of color in San Francisco

    AIDS Behav

    (2006)
  • L Khan

    Transgender health at the crossroads: legal norms, insurance markets, and the threat of health care reform

    Yale J Health Policy Law Ethics

    (2011)
  • J Drescher

    Queer diagnoses: parallels and contrasts in the history of homosexuality, gender variance, and the Diagnostic and Statistical Manual (DSM)

    Arch Sex Behav

    (2010)
  • HF Meyer-Bahlburg

    From mental disorder to iatrogenic hypogonadism: dilemmas in conceptualizing gender identity variants as psychiatric conditions

    Arch Sex Behav

    (2010)
  • Resolution of 28 September 2011 on human rights, sexual orientation and gender identity at the United Nations

  • Diagnostic and Statistical Manual of Mental Disorders

    (2013)
  • WP Bouman et al.

    World Professional Association for Transgender Health consensus statement on considerations of the role of distress (Criterion D) in the DSM diagnosis of gender identity disorder

    Int J Transgend

    (2010)
  • Cited by (0)

    View full text